A detailed history of Waycross Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Waycross Partners, LLC holds 4,557 shares of BMY stock, worth $261,252. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,557
Holding current value
$261,252
% of portfolio
0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$39.66 - $51.75 $180,730 - $235,824
4,557 New
4,557 $235,000
Q2 2021

Aug 17, 2021

BUY
$61.91 - $67.42 $207,831 - $226,328
3,357 Added 279.75%
4,557 $304,000
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $207,831 - $226,328
-3,357 Reduced 73.67%
1,200 $1.86 Million
Q4 2020

Feb 08, 2021

BUY
$57.74 - $65.43 $263,121 - $298,164
4,557 New
4,557 $283,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Waycross Partners, LLC Portfolio

Follow Waycross Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waycross Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waycross Partners, LLC with notifications on news.